Genome & Company (KOSDAQ:314130)
 2,910.00
 +55.00 (1.93%)
  At close: Oct 28, 2025
Genome & Company Market Cap
Genome & Company has a market cap or net worth of 99.94 billion as of October 30, 2025. Its market cap has decreased by -9.44% in one year.
Market Cap 
 99.94B
Enterprise Value 
 94.00B
Revenue 
 24.02B
Ranking 
 n/a
PE Ratio 
 n/a
Stock Price 
2,910.00
Market Cap Chart
Since December 26, 2018, Genome & Company's market cap has increased from 71.88B to 99.94B, an increase of 39.04%. That is a compound annual growth rate of 4.93%.
Market Cap History
| Date | Market Cap | % Change | 
|---|---|---|
| Oct 30, 2025 | 99.94B | 17.29% | 
| Dec 30, 2024 | 85.21B | -51.64% | 
| Dec 28, 2023 | 176.21B | -28.34% | 
| Dec 29, 2022 | 245.90B | -47.55% | 
| Dec 30, 2021 | 468.83B | -55.28% | 
| Dec 30, 2020 | 1.05T | 224.28% | 
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro | 
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro | 
| Dec 26, 2018 | Upgrade Pro | Upgrade Pro | 
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
 Full DefinitionRelated Stocks
| Company | Market Cap | 
|---|---|
| Samsung Electronics | 647.62T | 
| SK hynix | 359.70T | 
| LG Energy Solution | 119.34T | 
| Samsung Biologics | 87.69T | 
| Doosan Enerbility | 55.34T | 
| Hyundai Motor Company | 54.66T | 
| HD Hyundai Heavy Industries | 52.73T | 
| Hanwha Aerospace | 51.24T |